Freeze-dried cold kit for preparation of 99mTc-ciprofloxacin as an infection imaging agent

Iranian Journal of Nuclear Medicine

Volumn 18, Issue 2, 2010, Pages 45-51

  Mirshojaei, Seyedeh Fatemeh ^a   Erfani, Mostafa ^a   Sadat Ebrahimi, Seyed Esmaeil ^b   Talebi, Mohammad Hossein ^a   Abbasi, Farhad Haj Hassan ^a  

^a NUCLEAR SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

99mTc ciprofloxacin; Infection imaging; Kit preparation

Indexed keywords

CIPROFLOXACIN; CIPROFLOXACIN TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM; BLOOD; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; DRUG PURITY; DRUG STABILITY; DRUG STRUCTURE; FREEZE DRYING; IN VITRO STUDY; ISOTOPE LABELING; KIDNEY CLEARANCE; MALE; MOUSE; MUSCLE; NONHUMAN; PH; ROOM TEMPERATURE; SCINTIGRAPHY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 79961014249     PISSN: 16812824     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Becker W. The contribution of nuclear medicine to the patient with infection. Eur J Nucl Med. 1995;22(10):1195-1211.
2. st century. Braz Arch Biol Technol. 2002;45:25-37.
3. Pak KY, Nedelman MA, Tam SH, Wilson E, Daddona PE. Labeling and stability of radiolabeled antibody fragments by a direct 99mTc-labeling method. Int J Rad Appl Instrum B. 1992;19(6):669-677.
4. Signore A, D'Alessandria C, Annovazzi A, Scopinaro F. Radiolabeled cytokines for imaging chronic inflammation. Braz Arch Biol Tech. 2002;45:15-23.
5. Knight LC. Non-oncologic applications of radiolabeled peptides in nuclear medicine. Q J Nucl Med. 2003;47(4):279-291. (Pubitemid 38418048)
6. Weiner RE, Thakur ML. Radiolabeled peptides in diagnosis and therapy. Semin Nucl Med. 2001;31(4):296-311. (Pubitemid 33027508)
7. Cardoso VN, Plaza PJ, Roca M, Armero F, Martín-Comin J. Assessment of inflammatory bowel disease by using two different (99m)Tc leucocyte labelling methods. Nucl Med Commun. 2002;23(8):715-720. (Pubitemid 34837000)
8. Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev. 2003;55(1):27-55. (Pubitemid 36268398)
9. Gandomkar M, Najafi R, Shafiei M, Mazidi M, Goudarzi M, Mirfallah SH et al. Clinical evaluation of antimicrobial peptide [(99m)Tc/Tricine/HYNIC(0)] ubiquicidin 29-41 as a human-specific infection imaging agent. Nucl Med Biol. 2009;36(2):199-205.
10. Gandomkar M, Najafi R, Mazidi M, Goudarzi M, Mirfallah SH. New peptid based freezed-dried kit [99mTc-HYNIC]-UBI 29-41 as a human specific infection imaging agent. Iran J Nucl Med. 2008;16(1):25-30.
11. Gandomkar M, R. Najafi, Mazidi M, Mirfallah SH, Goudarzi M. Three different procedures in labeling of Ubiquicidin with technetium 99m: a comparative study. Iran J Radiat Res. 2009;7(2):97-104.
12. Martin-Comin J, Cardoso VN, Plaza P, Roca M. Hank's balanced salt solution: an alternative resuspension medium to label autologous leukocytes. Braz Arch Biol Technol. 2002;45:39-44.
13. Britton KE, Vinjamuri S, Hall AV, Solanki K, Siraj QH, Bomanji J et al. Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection. Eur J Nucl Med. 1997;24(5):553-556. (Pubitemid 27239215)
14. Fournier B, Zhao X, Lu T, Drlica K, Hooper DC. Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis. Antimicrob Agents Chemother. 2000;44(8):2160-2165. (Pubitemid 30484442)
15. Solanki KK, Bomanji J, Siraj Q, Small M, Britton KE. Tc-99m Infecton: A new class of radiopharmaceutical for imaging infection. J Nucl Med. 1993;34(Suppl):119 P.
16. 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med. 2003;44(6):920-926. (Pubitemid 39663404)
17. Bhardwaj N, Bhatnagar A, Singh AK. Development and evaluation of a single vial cold kit for infection imaging: Tc-99m ciprofloxacin. World J Nucl Med. 2005;4:244-251.
18. Hooper DC, Wolfson JS. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrob Agents Chemother. 1985;28(5):716-721. (Pubitemid 16215549)
19. 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet. 1996;347(8996):233-235.
20. Sing AK, Bhatnagar A, Singh T, Mathew TL. A process for preparation of technetium 4-fluoroquinolone metallic complexes. Indian Patent Filed. 2001;May.